Found 31 matching trials
Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma PHASE2 RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Show More Location
Stanford Cancer Center
Learn More & Join Trial
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) PHASE3 The purpose of this clinical trial is to evaluate efficacy and safety of ti...
Show More Location
Mayo Clinic Cancer Center
Learn More & Join Trial
O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas PHASE1 This phase I/II trial studies the side effects and best dose of temozolomid...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma PHASE2 This pilot phase II trial studies how well giving brentuximab vedotin, comb...
Show More Status
Active Not Recruiting
Location
Lucile Packard Children's Hospital Stanford University
Learn More & Join Trial
UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors PHASE1 Irinotecan is a commonly used salvage chemotherapy drug for children with r...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma PHASE3 Combined modality therapy has then emerged as the standard of care for limi...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma PHASE1 This study aims to see if reducing blood sugar and increasing ketones (a me...
Show More Location
Barrow Neurological Institute at St. Joseph's Hospital and Medical Center
Learn More & Join Trial
Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma PHASE2 RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Show More Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma PHASE2 Children, adolescents and young adults with high risk relapsed or treatment...
Show More Location
University Hospital Regensburg, Department of Pediatric Hematology and Oncology
Learn More & Join Trial
Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma PHASE1 This phase I/Ib trial tests the safety, side effects, and best dose of myco...
Show More Status
Active Not Recruiting
Location
Northwestern University
Learn More & Join Trial